Method for producing scaffold-free three-dimensional cartilage tissue, scaffold-free three-dimensional cartilage tissue, and modularized polyimide porous membrane for producing scaffold-free three-dimensional cartilage tissue

A scaffold-free method using a modular polyimide porous membrane and shear stress culture addresses the challenges of producing cartilage tissue by enhancing mechanical strength and thickness, ensuring safety and reproducibility through chondrocyte-derived extracellular matrix production.

JP7589853B2Active Publication Date: 2024-11-26UBE CORPORATION
View PDF 10 Cites 0 Cited by

Patent Information

Application Number
JP2024047280
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2024-03-22
Publication Date
2024-11-26
Estimated Expiration
2044-03-22

AI Technical Summary

Technical Problem

Existing methods for producing cartilage tissue in regenerative medicine face challenges such as contamination with non-human components, lack of mechanical strength, difficulty in handling, and the need for specialized equipment, while maintaining the integrity and extracellular matrix of cartilage-specific components.

Method used

A scaffold-free method using a modular polyimide porous membrane seeded with chondrocytes, subjected to shear stress through suspension culture, which promotes the production of a three-dimensional cartilage tissue with enhanced mechanical strength and thickness, containing primarily chondrocyte-derived extracellular matrix.

Benefits of technology

The method produces a cartilage tissue with higher cell and extracellular matrix content, superior strength, and ease of handling, without animal-derived components, ensuring safety and reproducibility.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007589853000004
    Figure 0007589853000004
  • Figure 0007589853000005
    Figure 0007589853000005
  • Figure 0007589853000006
    Figure 0007589853000006
Patent Text Reader

Abstract

To provide a cartilage tissue body that has sufficient dynamic strength and thickness, and does not contain a scaffold component derived from other animals, and has high safety.SOLUTION: Provided is a method for producing a scaffold-free three-dimensional cartilage tissue body including a process of floating a modularized polyimide porous membrane on which a cartilage cell is inoculated in a culture medium in a state where the membrane is not fixed inside a cell culture vessel for suspension culture, and culturing the membrane while shear stress is imparted to the modularized polyimide porous membrane. Further, provided is the scaffold-free three-dimensional cartilage tissue body, and a modularized polyimide porous membrane for producing the scaffold-free three-dimensional cartilage tissue body.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a method for producing a scaffold-free three-dimensional cartilage tissue, a scaffold-free three-dimensional cartilage tissue, and a modularized polyimide porous membrane for producing a scaffold-free three-dimensional cartilage tissue. [Background technology]

[0002] Cartilage tissue is a tissue without nerves or blood vessels, and is composed of chondrocytes and extracellular matrix (type II collagen, proteoglycan, water, etc.). In addition, when damaged, it is difficult to supply the nutrients necessary for repair, so it is said that natural repair is difficult. For this reason, various treatment methods have been adopted, such as high osteotomy by surgery and replacement with artificial joints. In recent years, many regenerative medicine methods have been created in which autologous cells are cultured and proliferated, and then embedded in the damaged area to heal the damaged area. Chondrocytes are easily dedifferentiated cells whose characteristics are lost in the usual plate culture method, but as a result of various research, various culture methods that maintain their characteristics have been devised. In addition, it has been found that it is important from the perspective of healing to embed not only cells but also the extracellular matrix specific to chondrocytes (glucosaminoglycan and type II collagen) in the affected area together with the cells, so much research has been carried out on the point of producing these extracellular matrices abundantly during cell culture. Through these efforts, several products have been launched as the results of research and development and are now used in medical settings. As these methods have begun to be used in practice, problems have been identified with each methodology, and solutions to these problems have been desired.

[0003] (i) Composition (contamination of components other than those derived from humans): In order to maintain cartilage characteristics and produce extracellular matrix optimally, some products use a methodology that uses a culture substrate. However, the culture substrate is basically a foreign substance and not a human-derived component.

[0004] (ii) Extracellular matrix: Embedding the cartilage-specific extracellular matrix together with cells is an important element in treatment. There is a high need to perform transplantation in a state rich in this matrix.

[0005] (iii) Cell number: Since the main source of healing is the transplanted chondrocytes, it is important to embed a large number of cells in a limited area.

[0006] (iv) Strength and size: In order to firmly embed and fix the implant in the affected area, it is important that the implant has strength and size that is not easily lost from the affected area and that allows easy handling during surgery.

[0007] (v) Handling: Since living cells are used as the embedding material, it is important to handle the embedded cells from the culture device easily, efficiently, and reproducibly before total embedding.

[0008] (vi) Integrity of the embedded material: Since the material will be embedded in humans, it is required that it grows satisfactorily. However, it is also important that the culture process is carried out in a xeno-free state, free of foreign matter.

[0009] (vii) Ease of use: It is desirable that the procurement of embedded tissues can be easily carried out at each site, and therefore it is desirable that no special equipment is required for the culture process.

[0010] In response to the above issues, methods proposed for cartilage regenerative medicine include injecting or transplanting into the affected area suspensions of chondrocytes, spheroids (spherical cell aggregates in which cells gather and aggregate), chondrocyte sheets made using temperature-responsive polymers, and cultured cartilage made by culturing chondrocytes in scaffolds.

[0011] (1) Cell suspensions and spheroids The method using the cell suspension involves collecting a small amount of cartilage tissue from the non-weight bearing part of a patient with a cartilage defect, isolating chondrocytes by enzyme treatment, culturing them in a monolayer, and then collecting the cells about three weeks later and injecting them into the cartilage defect in the form of a cell suspension. In order to keep the injected cells in the cartilage defect, the defect is patched with periosteum taken from the patient's tibia in advance, sealed with fibrin glue, and then the cell suspension is injected. This method was announced by a Swedish orthopedic surgeon in 1994 and was revolutionary in that it applied regenerative medicine to bone defect treatment, but since the cells are injected in the form of a suspension, there is a risk of leakage after surgery, and the cells will settle due to gravity after surgery, resulting in uneven repair tissue. In addition, Patent Document 1 proposes spheroids for cell transplantation therapy, but since they are small, with a diameter of 1 mm or less, there is a risk of leakage, as with cell suspensions, when applied to affected areas with a diameter of 1 mm or more. For this reason, measures such as fixing the spheroids to a sheet-like structure before transplanting them have been taken. In other words, since fluid transplant materials lack autonomy, there is a risk of cells leaking out, and measures to prevent this are necessary. In addition, while it is possible to secure the number of cells, no special measures are taken to secure the extracellular matrix, and it can be said that this method is focused on transferring a large number of cells.

[0012] (2) Cartilage cell sheets fabricated using temperature-responsive polymers As a transplant material with fixed cells, for example, Patent Document 2 proposes a cell sheet produced by culturing chondrocytes in a culture vessel treated with a temperature-responsive polymer. This sheet does not produce type II collagen specific to cartilage during culture, but has been described as producing good results of type II collagen after transplantation into an animal. However, the method using a temperature-responsive polymer has a problem that the cell sheet is thin, at only a few tens of μm, as described in Table 1 of Patent Document 2, so that the mechanical strength is weak and the sheet shrinks when the cell sheet is peeled off from the culture vessel. In this regard, for example, Patent Document 3 proposes a method of laminating the sheet to make it thicker and a method of adhering the culture sheet to a carrier to make it easier to peel off. However, it is described that the number of laminations is preferably 4 or less, because oxygen and nutrients are less likely to reach a cell sheet that is laminated more than 10 times. In this way, it can be said that it is difficult to form a thick tissue using a temperature-responsive polymer.

[0013] (3) Cultured cartilage produced by culturing chondrocytes in the scaffold As a transplant material in which cells are fixed and which has a thickness, a transplant material prepared using a natural or artificial scaffold material has been proposed. For example, Patent Document 4 and Patent Document 5 propose a transplant material prepared by seeding or embedding chondrocytes in a gel-like structure containing collagen and proteoglycan and culturing it. This method can provide a transplant material with a thickness depending on the size and amount of the scaffold. However, since the scaffold uses collagen derived from other animals, such as bovine or porcine collagen, the impact on the human body cannot be ignored. In addition, the collagen solution used has a high concentration and high viscosity, collagen immediately gels at 37°C, and there are issues with the uniformity of the prepared transplant material.

[0014] <Porous polyimide film> A method for culturing cells has been reported, which involves applying cells to a polyimide porous membrane and culturing the cells (Patent Document 6).

[0015] Polyimide is a general term for polymers that contain imide bonds in the repeating units. Aromatic polyimide refers to a polymer in which aromatic compounds are directly linked by imide bonds. Aromatic polyimides have a rigid and strong molecular structure because aromatics have a conjugated structure via imide bonds, and the imide bonds have strong intermolecular forces, so they have very high levels of thermal, mechanical, and chemical properties.

[0016] Polyimide porous films have been used for applications, particularly battery-related applications, such as filters, low-dielectric constant films, and electrolyte membranes for fuel cells, since before the filing of this application. Patent documents 7 to 10 describe polyimide porous films that have excellent permeability to substances such as gases, high porosity, excellent smoothness on both surfaces, relatively high strength, and, despite their high porosity, have a large number of macrovoids that are excellent in resistance to compressive stress in the thickness direction of the film. All of these polyimide porous films are prepared via amic acid. [Prior art documents] [Patent documents]

[0017] [Patent Document 1] JP 2011-41472 A [Patent Document 2] International Publication No. 2018 / 154813 [Patent Document 3] JP 2014-155494 A [Patent Document 4] JP 2001-293081 A [Patent Document 5] International Publication No. 2006 / 011296 [Patent Document 6] International Publication No. 2015 / 012415 [Patent Document 7] International Publication No. 2010 / 038873 [Patent Document 8] JP 2011-219585 A [Patent Document 9] JP 2011-219586 A [Patent Document 10] International Publication No. 2018 / 021368 Summary of the Invention [Problem to be solved by the invention]

[0018] In the field of cartilage regenerative medicine, various techniques have been developed and put to practical use, but they have the problems described above. Therefore, an object of the present invention is to provide a cartilage tissue having sufficient mechanical strength and thickness, which does not contain scaffold components derived from other animals, and which is highly safe. [Means for solving the problem]

[0019] In view of the above problems, the present inventors have conducted studies and found that a highly safe cartilage tissue construct that has sufficient mechanical strength and thickness and does not contain scaffold components derived from other animals can be prepared by a method simpler than conventional methods, leading to the completion of the present invention. That is, the present invention encompasses the following inventions.

[0020] [1] A method for producing a scaffold-free three-dimensional cartilage tissue construct, comprising: a step of culturing the modularized polyimide porous membrane seeded with chondrocytes while applying shear stress to the modularized polyimide porous membrane, while floating the modularized polyimide porous membrane in a medium in a cell culture vessel for suspension culture in an unfixed state; Including, The modularized polyimide porous membrane comprises a polyimide porous membrane and a casing in which the polyimide porous membrane is housed, and the polyimide porous membrane is fixed to the casing in a state in which the polyimide porous membrane does not continuously undergo wavy motion due to a fluid, The casing has one or more medium inlet / outlet ports for exposing a medium to at least a portion of the surface of the polyimide porous membrane; wherein the polyimide porous membrane is a three-layer structure polyimide porous membrane having surface layers A and B each having a plurality of pores, and a macrovoid layer sandwiched between the surface layers A and B, wherein the average pore size of the pores in the surface layer A is smaller than the average pore size of the pores in the surface layer B, the macrovoid layer has partition walls bonded to the surface layers A and B, and a plurality of macrovoids surrounded by the partition walls and the surface layers A and B, and the pores in the surface layers A and B are connected to the macrovoids. The method. [2] The method according to item 1, wherein the modularized polyimide porous film is housed in a stack of two or more of the polyimide porous films. [3] The method according to item 1 or 2, wherein the shear stress is induced by shaking and / or stirring while undergoing a swirling motion, a reciprocating motion, an up-and-down motion, a wave-type rocking motion, a rotational motion, or a combination of these motions. [4] The method according to any one of items 1 to 3, wherein the polyimide porous membrane has a plurality of pores having an average pore size of 0.01 to 100 μm. [5] The method according to any one of items 1 to 4, wherein the average pore size of the surface layer A is 0.01 to 50 μm. [6] The method according to any one of items 1 to 5, wherein the average pore size of the surface layer B is 20 to 100 μm. [7] The method according to any one of items 1 to 6, wherein the polyimide porous film has a total thickness of 5 to 500 μm. [8] The method according to any one of items 1 to 7, wherein the polyimide porous film is a polyimide porous film containing a polyimide obtained from a tetracarboxylic dianhydride and a diamine. [9] 9. The method according to any one of items 1 to 8, wherein the polyimide porous film is a colored polyimide porous film obtained by molding a polyamic acid solution composition containing a polyamic acid solution obtained from a tetracarboxylic dianhydride and a diamine and a colored precursor, and then heat-treating the resulting product at 250° C. or higher.

[0021]

[10] A scaffold-free three-dimensional cartilage tissue obtained by the method according to any one of items 1 to 9.

[0022]

[11] A scaffold-free three-dimensional cartilage tissue comprising chondrocytes, The present invention does not include any externally added scaffold components other than the extracellular matrix produced by the chondrocytes, The scaffold-free three-dimensional cartilage tissue has an average thickness of 0.2 mm or more, A scaffold-free three-dimensional cartilage tissue, characterized in that it contains 5 μg or more of glycosaminoglycan per 1 mg of wet weight.

[12] The scaffold-free three-dimensional cartilage tissue described in item 11, wherein the scaffold-free three-dimensional cartilage tissue has an average thickness of 0.5 mm or more.

[0023]

[13] A modularized polyimide porous membrane for producing a scaffold-free three-dimensional cartilage tissue, comprising: The modularized polyimide porous membrane comprises a polyimide porous membrane and a casing in which the polyimide porous membrane is housed, and the polyimide porous membrane is fixed to the casing in a state in which the polyimide porous membrane does not continuously undergo wavy motion due to a fluid, The casing has one or more medium inlet / outlet ports for exposing a medium to at least a portion of the surface of the polyimide porous membrane; wherein the polyimide porous membrane is a three-layer structure polyimide porous membrane having surface layers A and B each having a plurality of pores, and a macrovoid layer sandwiched between the surface layers A and B, wherein the average pore size of the pores in the surface layer A is smaller than the average pore size of the pores in the surface layer B, the macrovoid layer has partition walls bonded to the surface layers A and B, and a plurality of macrovoids surrounded by the partition walls and the surface layers A and B, and the pores in the surface layers A and B are connected to the macrovoids, The modularized polyimide porous film is used in a cell culture vessel, a cell culture device, or a cell culture system for suspension culture, and is not fixed within a culture section of the cell culture vessel, the cell culture device, or the cell culture system for suspension culture.

[14] The modularized polyimide porous film according to item 13, wherein two or more of the polyimide porous films are stacked and housed.

[15] The modularized polyimide porous film according to item 13 or 14, wherein the polyimide porous film has a plurality of pores having an average pore size of 0.01 to 100 μm.

[16] The modularized polyimide porous membrane according to any one of items 13 to 15, wherein the surface layer A has an average pore size of 0.01 to 50 μm.

[17] The modularized polyimide porous membrane according to any one of items 13 to 16, wherein the surface layer B has an average pore size of 20 to 100 μm.

[18] The modularized polyimide porous film according to any one of items 13 to 17, wherein the polyimide porous film has a total thickness of 5 to 500 μm.

[19] The modularized polyimide porous film according to any one of items 13 to 18, wherein the polyimide porous film contains a polyimide obtained from a tetracarboxylic dianhydride and a diamine.

[20] The modularized polyimide porous film according to any one of items 13 to 19, wherein the polyimide porous film is a colored polyimide porous film obtained by molding a polyamic acid solution composition containing a polyamic acid solution obtained from a tetracarboxylic dianhydride and a diamine and a colored precursor, and then heat-treating the resulting product at 250° C. or higher. Effect of the Invention

[0024] According to the present invention, it is possible to provide a three-dimensional cartilage tissue having sufficient mechanical strength and thickness compared to three-dimensional cartilage tissue obtained by conventional methods. Furthermore, the three-dimensional cartilage tissue provided by the present invention has a higher cell amount and extracellular matrix amount than conventional ones, and has excellent strength, and is easy to collect when produced and has excellent reproducibility. Furthermore, the three-dimensional cartilage tissue obtained by the present invention is mainly composed of chondrocytes and the extracellular matrix produced by the cells themselves, and does not contain any components derived from other animals, so it is highly safe for the living body. [Brief description of the drawings]

[0025] [Figure 1] FIG. 1 shows one embodiment of a modularized polyimide porous membrane. [Diagram 2] 2 shows one embodiment of the modularized polyimide porous membrane. 1 is a top view of the modularized polyimide porous membrane of FIG. [Diagram 3] 3 shows one embodiment of the modularized polyimide porous membrane, which is a diagram showing the AA' cross section of the modularized polyimide porous membrane of FIG. [Figure 4] FIG. 4 shows a model diagram of cell culture using a polyimide porous membrane. [Diagram 5] FIG. 5 shows the modularized polyimide porous membrane used in the examples. [Figure 6] 6 is a photograph of the scaffold-free three-dimensional cartilage tissue obtained in the Examples. Upper: scaffold-free three-dimensional cartilage tissue constructed on a polyimide porous membrane after the casing member was removed, lower: scaffold-free three-dimensional cartilage tissue peeled off from the polyimide porous membrane. [Figure 7] FIG. 7 shows the results of comparing the amount of DNA or glycosaminoglycan contained in the three-dimensional cartilage tissue prepared in the Examples and Comparative Examples. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0026] I. Method for producing scaffold-free three-dimensional cartilage tissue construct

[0027] In one embodiment, the present invention provides A method for producing a scaffold-free three-dimensional cartilage tissue construct, comprising: a step of culturing the modularized polyimide porous membrane seeded with chondrocytes while applying shear stress to the modularized polyimide porous membrane, while floating the modularized polyimide porous membrane in a medium in a cell culture vessel for suspension culture in an unfixed state; Including, The modularized polyimide porous membrane comprises a polyimide porous membrane and a casing in which the polyimide porous membrane is housed, and the polyimide porous membrane is fixed to the casing in a state in which the polyimide porous membrane does not continuously undergo wavy motion due to a fluid, The casing has one or more medium inlet / outlet ports for exposing a medium to at least a portion of the surface of the polyimide porous membrane; wherein the polyimide porous membrane is a three-layer structure polyimide porous membrane having surface layers A and B each having a plurality of pores, and a macrovoid layer sandwiched between the surface layers A and B, wherein the average pore size of the pores in the surface layer A is smaller than the average pore size of the pores in the surface layer B, the macrovoid layer has partition walls bonded to the surface layers A and B, and a plurality of macrovoids surrounded by the partition walls and the surface layers A and B, and the pores in the surface layers A and B are connected to the macrovoids. The method is provided.

[0028] 1.Chondrocytes As used herein, the term "chondrocyte" refers to a cell that produces extracellular matrix that constitutes cartilage tissue, such as collagen or proteoglycan, or a precursor cell thereof (e.g., mesenchymal stem cell, osteoblast, or chondroblast). The chondrocyte that can be applied to the present invention may be a cell that expresses a chondrocyte marker, and examples of the chondrocyte marker include, but are not limited to, type II collagen (COL2A1) or SOX9. Examples of COL2A1 include, but are not limited to, a gene having a nucleotide sequence described in, for example, NCBI accession numbers NM_001844 or NM_033150 for humans and NM_001113515 or NM_031163 for mice, as well as a protein encoded by the gene, and naturally occurring mutants having these functions. In addition, SOX9 includes, for example, a gene having a nucleotide sequence set forth in NCBI accession number NM_000346 for humans and NM_011448 for mice, as well as a protein encoded by the gene, and naturally occurring mutants having these functions, but are not limited to these.

[0029] The chondrocytes that can be used in the present invention may be isolated from a biological tissue, for example, articular cartilage, auricular cartilage, or nasal cartilage, or may be harvested, for example, from an extra finger of a subject with polydactyly. Furthermore, the chondrocytes may be autologous cells harvested from the subject to be transplanted, or allogeneic cells harvested from a subject other than the subject to be transplanted.

[0030] The chondrocytes that can be used in the present invention may be chondrocytes induced to differentiate from pluripotent stem cells. Pluripotent stem cells are intended to be a general term for stem cells that have the ability to differentiate into cells of any tissue (differentiation pluripotency). Pluripotent stem cells include, but are not limited to, embryonic stem cells (ES cells), induced pluripotent stem cells (iPS cells), embryonic germ stem cells (EG cells), germ stem cells (GS cells), and the like. ES cells or iPS cells are preferred. iPS cells are particularly preferred because they have no ethical issues. Any known pluripotent stem cells can be used, and for example, the pluripotent stem cells described in International Publication WO2009 / 123349 (PCT / JP2009 / 057041) can be used. There is no particular limitation on the method of inducing differentiation of chondrocytes that can be applied to the present invention from pluripotent stem cells, and known methods, such as International Publication No. WO2016 / 133208, can be used as a reference.

[0031] 2. Scaffold-free 3D cartilage tissue

[0032] As used herein, the term "scaffold-free three-dimensional cartilage tissue" refers to a three-dimensional tissue containing chondrocytes that does not contain externally added scaffold components (e.g., atelocollagen, matrigel, gelatin, etc.) other than the extracellular matrix generated by the chondrocytes themselves. That is, the "scaffold-free three-dimensional cartilage tissue" that can be provided by the present invention is a tissue generated by the chondrocytes themselves becoming three-dimensional by the extracellular matrix generated by the chondrocytes themselves, and has an average thickness of 0.2 mm or more, preferably an average thickness of 0.5 mm or more. In addition, the "scaffold-free three-dimensional cartilage tissue" that can be provided by the present invention is a structure that can contain 5 μg or more of glycosaminoglycan per mg of wet weight. The scaffold-free three-dimensional cartilage tissue that can be provided by the present invention has a higher cell amount and extracellular matrix amount than conventional ones, has excellent strength, and is easy to recover after production. Therefore, it is easy to handle. Furthermore, the scaffold-free three-dimensional cartilage tissue that can be provided by the present invention is mainly composed of chondrocytes and the extracellular matrix produced by the cells themselves, and therefore does not contain, for example, components derived from other animals, and therefore contains almost no substances that could become allergens that cause allergic reactions, making it highly safe.

[0033] 3. Modularized polyimide porous membrane The "modularized polyimide porous film" that can be used in the present invention or is provided in the present invention is The present invention comprises a polyimide porous film and a casing in which the polyimide porous film is housed, the polyimide porous film being fixed to the casing in a state in which the polyimide porous film does not continuously undergo wavy motion due to a fluid, The casing has one or more medium inlet / outlet ports for exposing a medium to at least a portion of the surface of the polyimide porous membrane; Here, the polyimide porous membrane is a three-layer structure polyimide porous membrane having surface layers A and B having a plurality of pores, and a macrovoid layer sandwiched between surface layers A and B, wherein the average pore size of the pores present in surface layer A is smaller than the average pore size of the pores present in surface layer B, the macrovoid layer has partition walls bonded to surface layers A and B, and a plurality of macrovoids surrounded by the partition walls and surface layers A and B, and the pores in surface layers A and B are connected to the macrovoids (see, for example, Figure 1).

[0034] The chondrocytes are attached to the surface of the modularized polyimide porous membrane at the portion that is open to the medium inlet and outlet of the membrane. In this state, the modularized polyimide porous membrane is suspended in a medium and cultured while applying shear stress, which promotes the production of extracellular matrix by the chondrocytes themselves and promotes the proliferation of the chondrocytes, resulting in the formation of a scaffold-free three-dimensional cartilage tissue that is thickened perpendicularly to the plane of the polyimide porous membrane.

[0035] The shape of the resulting scaffold-free three-dimensional cartilage tissue varies depending on the shape of the medium inlet / outlet of the modularized polyimide porous membrane. Therefore, when the intended use is, for example, transplantation, the shape of the medium inlet / outlet of the modularized polyimide porous membrane may be designed according to the shape, size, etc. of the transplant site, and the shape and size of the medium inlet / outlet may be designed to any shape and size, such as rectangular, circular, elliptical, triangular, pentagonal, or hexagonal.

[0036] In one embodiment, the modularized polyimide porous membrane may have two or more medium inlets. For example, a plurality of medium inlets may be provided on the same surface of the casing of the modularized polyimide porous membrane, or a plurality of medium inlets may be provided on both sides of the polyimide porous membrane housed in the casing (see FIG. 3).

[0037] The thickness of the scaffold-free three-dimensional cartilage tissue can be changed by adjusting the thickness of the opening constituting the medium inlet / outlet of the modularized polyimide porous membrane, that is, the thickness of the casing that houses the polyimide porous membrane. For example, if the thickness of the casing is 0.2 mm, the medium inlet / outlet becomes an opening having a depth of 0.2 mm from the surface of the casing to the surface of the polyimide porous membrane (hereinafter referred to as the "medium inlet / outlet thickness") (see FIG. 3). On the surface of the polyimide porous membrane that has become the recess, chondrocytes grow vertically, and become a scaffold-free three-dimensional cartilage tissue with its own thickness. By changing the thickness of the medium inlet / outlet, it is possible to adjust the thickness of the obtained scaffold-free three-dimensional cartilage tissue, and for example, a casing having a thickness of 0.3 mm or more, 0.4 mm or more, 0.5 mm or more, 0.6 mm or more, 0.7 mm or more, 0.8 mm or more, 0.9 mm or more, 1.0 mm or more, or more may be used.

[0038] In one embodiment of the modularized polyimide porous membrane, the surface of the polyimide porous membrane exposed to the culture medium is preferably the surface layer B. If the modularized polyimide porous membrane is arranged so that the surface layer B of the polyimide porous membrane is in contact with the culture medium inlet / outlet, the scaffold-free three-dimensional cartilage tissue formed at the culture medium inlet / outlet can be easily peeled off, making it easy to recover.

[0039] In one embodiment, the modularized polyimide porous membrane may have a casing composed of disassembled parts. For example, as shown in Figs. 1 to 3, the modularized polyimide porous membrane may have a rectangular medium inlet / outlet at the center, and may be fixed by sandwiching two or more laminated polyimide porous membranes from both sides with a flat casing member of approximately the same shape as the polyimide porous membrane and sandwiching both ends with two or more binders. If the casing of the modularized polyimide porous membrane is disassembled, the prepared scaffold-free three-dimensional cartilage tissue can be easily collected. In one embodiment, when a plurality of polyimide porous membranes are used in a laminated form, the outermost polyimide porous membrane may be arranged so that the surface layer B is in contact with the medium inlet / outlet.

[0040] In this specification, the term "modularized polyimide porous film" may simply be described as "module", and these terms may be interchanged to mean the same thing.

[0041] In this specification, the "modularized polyimide porous membrane" refers to a cell culture substrate that can be applied to cell culture vessels, cell culture devices, and cell culture systems, particularly cell culture vessels, cell culture devices, and cell culture systems used in suspension culture. The modularized polyimide porous membrane (cell culture module) described in International Publication WO2018 / 021368 can also be applied to the present invention. As an example, the modularized polyimide porous membrane of the present invention can be used in an embodiment using a WAVE reactor. It can also be used in an embodiment using an Erlenmeyer reactor.

[0042] The modularized polyimide porous membrane of the present invention is housed in a casing, and thus the membrane-like polyimide porous membrane is prevented from being continuously deformed within the casing. This prevents stress from being applied to cells growing inside the polyimide porous membrane, and apoptosis and the like are suppressed, making it possible to stably culture a large number of cells. In addition, the modularized polyimide porous membrane that can be used in the present invention can form a scaffold-free three-dimensional cartilage tissue by culturing in suspension culture under a rotating motion, a reciprocating motion, an up-down motion, a wave-type rocking motion, or a combination of these motions, which strongly loads shear stress.

[0043] The casing of the modularized polyimide porous membrane of the present invention preferably has a strength sufficient to prevent deformation due to the movement of the culture medium under normal culture conditions, such as stirring culture and shaking culture conditions. In addition, the casing is preferably made of a material that does not affect cell growth in cell culture. Examples of such materials include, but are not limited to, polymers such as polyethylene, polypropylene, nylon, polyester, polystyrene, polycarbonate, polymethyl methacrylate, and polyethylene terephthalate, and metals such as stainless steel and titanium. If the casing has a certain degree of strength, the shape of the polyimide porous membrane inside the casing is prevented from continuously deforming, and the effects of the present invention are more effectively exhibited. In this specification, "the casing does not deform" means that the casing does not deform under the load received under a normal culture environment, and does not mean that the casing absolutely does not deform.

[0044] In one embodiment, the modularized polyimide porous membrane that can be used or provided in the present invention is a laminate of two or more polyimide porous membranes and housed in a casing. In this case, an insole may be provided between the polyimide porous membranes. By providing the insole, the culture medium can be efficiently supplied between the laminated polyimide porous membranes. The insole is not particularly limited as long as it has the function of forming an arbitrary space between the laminated polyimide porous membranes and efficiently supplying the culture medium, and for example, a planar structure having a mesh structure can be used. The material of the insole can be, for example, polystyrene, polycarbonate, polymethyl methacrylate, polyethylene terephthalate, or stainless steel mesh, but is not limited thereto. When the insole has a mesh structure, it is sufficient that the mesh has an opening large enough to supply the culture medium between the laminated polyimide porous membranes, and can be appropriately selected.

[0045] In this specification, the term "folded polyimide porous membrane" refers to a polyimide porous membrane that is folded in the casing and is immobilized in the casing due to friction between each surface of the polyimide porous membrane and / or the surface inside the casing. In this specification, "folded" may refer to a state in which the polymer porous membrane has creases or does not have creases.

[0046] In this specification, "a state in which the polyimide porous membrane does not move within the casing" refers to a state in which the modularized polyimide porous membrane is housed within the casing so that the polyimide porous membrane does not continuously change shape when cultured in a cell culture medium. In other words, the polyimide porous membrane itself is restrained by the fluid so as not to continuously undulate. Since the polyimide porous membrane is kept in a state of not moving within the casing, stress is prevented from being applied to the cells growing within the polyimide porous membrane, and the cells can be stably cultured without dying due to apoptosis or the like.

[0047] In one embodiment, the modularized polyimide porous membrane that can be used in the present invention is suspended in a medium without being fixed in a cell culture vessel for suspension culture, and cultured under conditions that apply shear stress to the modularized polyimide porous membrane. This promotes the proliferation of chondrocytes growing on the polyimide porous membrane located at the medium inlet / outlet of the modularized polyimide porous membrane, and a thickened scaffold-free three-dimensional cartilage tissue is obtained.

[0048] The shear stress can be imparted by applying the modularized polyimide porous membrane to commercially available culture vessels, culture devices, and systems that can be stirred in a state of, for example, rotational motion, reciprocating motion, up-down motion, wave-type rocking motion, or a combination of these motions. For example, the modularized polyimide porous membrane of the present invention can be applied to a culture device in which the culture vessel is made of a flexible bag, and can be used in a state where it is suspended in the culture vessel. In addition, the modularized polyimide porous membrane of the present invention can be applied to a stirring reactor such as a spinner flask for culture. In addition, the modularized polyimide porous membrane of the present invention can be applied to an open vessel or a closed vessel. For example, a petri dish, flask, plastic bag, test tube, or large tank for cell culture can be appropriately used. For example, the modularized polyimide porous membrane includes a cell culture dish manufactured by BD Falcon and a Nunc Cell Factory manufactured by Thermo Scientific.

[0049] 4. Application of modularized polyimide porous membrane to cell culture device In this specification, the term "cell culture device" is generally a term that is treated as synonymous with a cell culture system, a bioreactor, or a reactor, and has the same meaning when used interchangeably.

[0050] 5.Porous polyimide membrane The average pore size of the pores present in the surface layer A (hereinafter also referred to as "side A" or "mesh side") in the polyimide porous film used in the present invention is not particularly limited, and is, for example, 0.01 μm or more and less than 200 μm, 0.01 to 150 μm, 0.01 to 100 μm, 0.01 to 50 μm, 0.01 μm to 40 μm, 0.01 μm to 30 μm, 0.01 μm to 20 μm, or 0.01 μm to 15 μm, and preferably 0.01 μm to 15 μm.

[0051] The average pore size of the pores present in the surface layer B (hereinafter also referred to as "side B" or "large hole side") in the polyimide porous film used in the present invention is not particularly limited as long as it is larger than the average pore size of the pores present in the surface layer A, and is, for example, more than 5 μm and not more than 200 μm, 20 μm to 100 μm, 30 μm to 100 μm, 40 μm to 100 μm, 50 μm to 100 μm, or 60 μm to 100 μm, and preferably 20 μm to 100 μm.

[0052] The average pore size of the surface of a polyimide porous membrane can be determined by measuring the pore areas of 200 or more openings in a scanning electron microscope photograph of the surface of the porous membrane, and calculating the average diameter from the average pore area according to the following formula (1), assuming that the pores are perfectly circular.

number

[0053] The thickness of the surface layers A and B is not particularly limited, but is, for example, 0.01 to 50 μm, and preferably 0.01 to 20 μm.

[0054] The average pore size of the macrovoids in the macrovoid layer in the polyimide porous film in the film plane direction is not particularly limited, but is, for example, 10 to 500 μm, preferably 10 to 100 μm, and more preferably 10 to 80 μm. The thickness of the partition walls in the macrovoid layer is not particularly limited, but is, for example, 0.01 to 50 μm, and preferably 0.01 to 20 μm. In one embodiment, at least one partition wall in the macrovoid layer has one or more holes with an average pore size of 0.01 to 100 μm, preferably 0.01 to 50 μm, which communicates with adjacent macrovoids. In another embodiment, the partition walls in the macrovoid layer have no pores.

[0055] The total thickness of the surface of the polyimide porous film used in the present invention is not particularly limited, but may be 5 μm or more, 10 μm or more, 20 μm or more, or 25 μm or more, and may be 500 μm or less, 300 μm or less, 100 μm or less, 75 μm or less, or 50 μm or less, preferably 5 to 500 μm, and more preferably 25 to 75 μm.

[0056] The thickness of the polyimide porous film used in the present invention can be measured by a contact type thickness meter.

[0057] The porosity of the polyimide porous film used in the present invention is not particularly limited, but is, for example, not less than 40% and less than 95%.

[0058] The porosity of the polyimide porous film used in the present invention can be calculated from the basis weight by measuring the thickness and mass of a porous film cut to a predetermined size according to the following formula (2).

number

[0059] The polyimide porous film used in the present invention is preferably a three-layered polyimide porous film having surface layers A and B each having a plurality of pores, and a macrovoid layer sandwiched between the surface layers A and B, wherein the average pore size of the pores in the surface layer A is 0.01 μm to 15 μm, and the average pore size of the pores in the surface layer B is 20 μm to 100 μm, the macrovoid layer has partition walls bonded to the surface layers A and B, and a plurality of macrovoids surrounded by the partition walls and the surface layers A and B, the partition walls of the macrovoid layer and the surface layers A and B have thicknesses of 0.01 to 20 μm, the pores in the surface layers A and B are connected to the macrovoids, the polyimide porous film has a total thickness of 5 to 500 μm, and a porosity of 40% or more and less than 95%. In one embodiment, at least one partition wall in the macrovoid layer has one or more pores that connect adjacent macrovoids and have an average pore size of 0.01 to 100 μm, preferably 0.01 to 50 μm. In another embodiment, the partition wall does not have such pores.

[0060] The polyimide porous membrane used in the present invention is preferably sterilized. The sterilization method is not particularly limited, but may be any sterilization method such as dry heat sterilization, steam sterilization, sterilization with a disinfectant such as ethanol, or electromagnetic sterilization using ultraviolet rays or gamma rays.

[0061] Polyimide is a general term for polymers containing imide bonds in the repeating units, and usually refers to aromatic polyimides in which aromatic compounds are directly linked by imide bonds. Aromatic polyimides have a rigid and strong molecular structure because aromatic compounds have a conjugated structure via imide bonds, and the imide bonds have strong intermolecular forces, so they have very high levels of thermal, mechanical, and chemical properties.

[0062] The polyimide porous film that can be used in the present invention is preferably a polyimide porous film containing (as a main component) a polyimide obtained from a tetracarboxylic dianhydride and a diamine, and more preferably a polyimide porous film consisting of a polyimide obtained from a tetracarboxylic dianhydride and a diamine. "Containing as a main component" means that the polyimide porous film does not essentially contain any component other than the polyimide obtained from the tetracarboxylic dianhydride and the diamine as a constituent component, or may contain such a component, but it is an additional component that does not affect the properties of the polyimide obtained from the tetracarboxylic dianhydride and the diamine.

[0063] In one embodiment, the polyimide porous film that can be used in the present invention also includes a colored polyimide porous film obtained by molding a polyamic acid solution composition containing a polyamic acid solution obtained from a tetracarboxylic acid component and a diamine component and a colored precursor, and then heat-treating the molded product at 250° C. or higher.

[0064] Polyamic acid is obtained by polymerizing a tetracarboxylic acid component and a diamine component. Polyamic acid is a polyimide precursor that can be converted into a polyimide by thermal or chemical imidization to close the ring.

[0065] The polyamic acid may be partially imidized as long as the imidization does not affect the present invention. That is, the polyamic acid may be partially thermally or chemically imidized.

[0066] When the polyamic acid is thermally imidized, an imidization catalyst, an organic phosphorus-containing compound, fine particles such as inorganic fine particles and organic fine particles, etc., can be added to the polyamic acid solution as necessary. When the polyamic acid is chemically imidized, a chemical imidization agent, a dehydrating agent, fine particles such as inorganic fine particles and organic fine particles, etc. can be added to the polyamic acid solution as necessary. It is preferable to carry out the process under conditions in which the color precursor does not precipitate even if the above-mentioned components are mixed into the polyamic acid solution.

[0067] In this specification, the term "colored precursor" refers to a precursor that is partially or completely carbonized by heat treatment at 250° C. or higher to produce a colored product.

[0068] The colored precursor that can be used in the production of the polyimide porous film is preferably one that is uniformly dissolved or dispersed in a polyamic acid solution or a polyimide solution, and is thermally decomposed by heat treatment at 250° C. or higher, preferably 260° C. or higher, more preferably 280° C. or higher, and more preferably 300° C. or higher, preferably in the presence of oxygen such as air, at 250° C. or higher, preferably 260° C. or higher, more preferably 280° C. or higher, and more preferably 300° C. or higher, and carbonized to produce a colored product, more preferably one that produces a black colored product, and more preferably a carbon-based colored precursor.

[0069] When the colored precursor is heated, it becomes what appears to be a carbonized product at first glance, but in terms of structure it contains elements other than carbon, and includes layered structures, aromatic bridged structures, and disordered structures including tetrahedral carbon.

[0070] The carbon-based coloring precursor is not particularly limited, and examples thereof include tar or pitch such as petroleum tar, petroleum pitch, coal tar, and coal pitch, coke, a polymer obtained from a monomer containing acrylonitrile, a ferrocene compound (ferrocene and ferrocene derivatives), etc. Among these, a polymer and / or a ferrocene compound obtained from a monomer containing acrylonitrile is preferred, and as a polymer obtained from a monomer containing acrylonitrile, polyacrylonitrile is preferred.

[0071] In another embodiment, the polyimide porous film that can be used in the present invention also includes a polyimide porous film obtained by molding a polyamic acid solution obtained from a tetracarboxylic acid component and a diamine component, without using the above-mentioned colored precursor, and then heat-treating the molded product.

[0072] The polyimide porous film produced without using a colored precursor may be produced, for example, by casting a polyamic acid solution consisting of 3-60% by mass of a polyamic acid having an intrinsic viscosity of 1.0-3.0 and 40-97% by mass of an organic polar solvent into a film, immersing or contacting the polyamic acid solution with a water-based coagulation solvent to produce a polyamic acid porous film, and then heat-treating the polyamic acid porous film to imidize it. In this method, the water-based coagulation solvent may be water or a mixture of 5% by mass or more and less than 100% by mass of water and more than 0% by mass and 95% by mass or less of an organic polar solvent. After the imidization, at least one side of the obtained porous polyimide film may be subjected to a plasma treatment.

[0073] The tetracarboxylic dianhydride that can be used in the production of the polyimide porous film may be any tetracarboxylic dianhydride, and may be appropriately selected depending on the desired properties, etc. Specific examples of tetracarboxylic dianhydrides include pyromellitic dianhydride, biphenyl tetracarboxylic dianhydrides such as 3,3',4,4'-biphenyl tetracarboxylic dianhydride (s-BPDA) and 2,3,3',4'-biphenyl tetracarboxylic dianhydride (a-BPDA), oxydiphthalic dianhydride, diphenylsulfone-3,4,3',4'-tetracarboxylic dianhydride, bis(3,4-dicarboxyphenyl)sulfide dianhydride, 2,2-bis(3,4-dicarboxyphenyl)-1,1,1,3,3,3-hexafluoropropane dianhydride, 2,3,3',4'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride, bis(3,4-dicarboxyphenyl)methane dianhydride, and 2,2-bis(3,4-dicarboxyphenyl)propane dianhydride, p-phenylene bis(trimellitic acid monoester acid anhydride), p-biphenylene bis(trimellitic acid monoester acid anhydride), m-terphenyl-3,4,3',4'-tetracarboxylic acid dianhydride, p-terphenyl-3,4,3',4'-tetracarboxylic acid dianhydride, 1,3-bis(3,4-dicarboxyphenoxy)benzene dianhydride, 1,4-bis(3,4-dicarboxyphenoxy)benzene dianhydride, 1,4-bis(3,4-dicarboxyphenoxy)biphenyl dianhydride, 2,2-bis[(3,4-dicarboxyphenoxy)phenyl]propane dianhydride, 2,3,6,7-naphthalene tetracarboxylic acid dianhydride, 1,4,5,8-naphthalene tetracarboxylic acid dianhydride, 4,4'-(2,2-hexafluoroisopropylidene)diphthalic dianhydride, and the like. It is also preferable to use aromatic tetracarboxylic acids such as 2,3,3',4'-diphenylsulfonetetracarboxylic acid, etc. These may be used alone or in combination of two or more kinds.

[0074] Among these, at least one aromatic tetracarboxylic dianhydride selected from the group consisting of biphenyltetracarboxylic dianhydride and pyromellitic dianhydride is particularly preferred. As the biphenyltetracarboxylic dianhydride, 3,3',4,4'-biphenyltetracarboxylic dianhydride can be suitably used.

[0075] The diamine that can be used in the production of the polyimide porous film may be any diamine. Specific examples of the diamine include the following: 1) Benzenediamines with one benzene nucleus, such as 1,4-diaminobenzene (paraphenylenediamine), 1,3-diaminobenzene, 2,4-diaminotoluene, and 2,6-diaminotoluene; 2) Diaminodiphenyl ethers such as 4,4'-diaminodiphenyl ether and 3,4'-diaminodiphenyl ether, 4,4'-diaminodiphenylmethane, 3,3'-dimethyl-4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl, 2,2'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 3,3'-dimethyl-4,4'-diaminodiphenylmethane, 3,3'-dicarboxy-4,4'-diaminodiphenylmethane, 3 ,3',5,5'-Tetramethyl-4,4'-diaminodiphenylmethane, Bis(4-aminophenyl)sulfide, 4,4'-diaminobenzanilide, 3,3'-Dichlorobenzidine, 3,3'-Dimethylbenzidine, 2,2'-Dimethylbenzidine, 3,3'-Dimethoxybenzidine, 2,2'-Dimethoxybenzidine, 3,3'-Diaminodiphenyl ether, 3,4'-Diaminodiphenyl ether, 4,4'-Diaminodiphenyl ether, 3,3'-Diaminodiphenyl Sulfide, 3,4'-diaminodiphenyl sulfide, 4,4'-diaminodiphenyl sulfide, 3,3'-diaminodiphenyl sulfone, 3,4'-diaminodiphenyl sulfone, 4,4'-diaminodiphenyl sulfone, 3,3'-diaminobenzophenone, 3,3'-diamino-4,4'-dichlorobenzophenone, 3,3'-diamino-4,4'-dimethoxybenzophenone, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 4,4'-di Diamines with two benzene nuclei, such as aminodiphenylmethane, 2,2-bis(3-aminophenyl)propane, 2,2-bis(4-aminophenyl)propane, 2,2-bis(3-aminophenyl)-1,1,1,3,3,3-hexafluoropropane, 2,2-bis(4-aminophenyl)-1,1,1,3,3,3-hexafluoropropane, 3,3'-diaminodiphenyl sulfoxide, 3,4'-diaminodiphenyl sulfoxide, and 4,4'-diaminodiphenyl sulfoxide; 3) 1,3-bis(3-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1,4-bis(3-aminophenyl)benzene, 1,4-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(3-aminophenoxy)benzene, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)-4-trifluoromethylbenzene, 3,3'-diamino-4-(4-phenyl)phenoxybenzophenone, 3,3'-diamino-4,4'-di(4-phenylphenoxy)benzophenone, 1,3 -Diamines with three benzene nuclei, such as bis(3-aminophenylsulfide)benzene, 1,3-bis(4-aminophenylsulfide)benzene, 1,4-bis(4-aminophenylsulfide)benzene, 1,3-bis(3-aminophenylsulfone)benzene, 1,3-bis(4-aminophenylsulfone)benzene, 1,4-bis(4-aminophenylsulfone)benzene, 1,3-bis[2-(4-aminophenyl)isopropyl]benzene, 1,4-bis[2-(3-aminophenyl)isopropyl]benzene, and 1,4-bis[2-(4-aminophenyl)isopropyl]benzene; 4) 3,3'-bis(3-aminophenoxy)biphenyl, 3,3'-bis(4-aminophenoxy)biphenyl, 4,4'-bis(3-aminophenoxy)biphenyl, 4,4'-bis(4-aminophenoxy)biphenyl, bis[3-(3-aminophenoxy)phenyl]ether, bis[3-(4-aminophenoxy)phenyl]ether, bis[4-(3-aminophenoxy)phenyl]ether, bis[4-(4-aminophenoxy)phenyl]ether, bis[3-(3-aminophenoxy)phenyl]ketone, bis[3-(4-aminophenoxy)phenyl]ketone, bis[4-(3-aminophenoxy)phenyl]ketone, bis[4-(4-aminophenoxy)phenyl]ketone, bis[3-(3-aminophenoxy)phenyl]sulfide, bis[3-(4-aminophenoxy)phenyl]sulfide, bis[4-(3-aminophenoxy)phenyl]sulfide, bis[4-(4-aminophenoxy)phenyl]sulfide, bis[3-(3-aminophenoxy)phenyl]sulfone, bis[3-(4-aminophenoxy)phenyl]sulfone, bis[4-(3-aminophenoxy)phenyl]sulfone bis[4-(4-aminophenoxy)phenyl]sulfone, bis[3-(3-aminophenoxy)phenyl]methane, bis[3-(4-aminophenoxy)phenyl]methane, bis[4-(3-aminophenoxy)phenyl]methane, bis[4-(4-aminophenoxy)phenyl]methane, 2,2-bis[3-(3-aminophenoxy)phenyl]propane, 2,2-bis[3-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(3-aminophenoxy)phenyl]propane, 2,2- Diamines with four benzene nuclei such as bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[3-(3-aminophenoxy)phenyl]-1,1,1,3,3,3-hexafluoropropane, 2,2-bis[3-(4-aminophenoxy)phenyl]-1,1,1,3,3,3-hexafluoropropane, 2,2-bis[4-(3-aminophenoxy)phenyl]-1,1,1,3,3,3-hexafluoropropane, and 2,2-bis[4-(4-aminophenoxy)phenyl]-1,1,1,3,3,3-hexafluoropropane.

[0076] These may be used alone or in combination of two or more. The diamine to be used may be appropriately selected depending on the desired properties.

[0077] Among these, aromatic diamine compounds are preferred, and 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 4,4'-diaminodiphenyl ether, paraphenylenediamine, 1,3-bis(3-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1,4-bis(3-aminophenyl)benzene, 1,4-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenoxy)benzene, and 1,4-bis(3-aminophenoxy)benzene can be suitably used. In particular, at least one diamine selected from the group consisting of benzenediamine, diaminodiphenyl ether, and bis(aminophenoxy)phenyl is preferred.

[0078] From the viewpoints of heat resistance and dimensional stability at high temperatures, the polyimide porous film that can be used in the present invention is preferably formed from a polyimide obtained by combining a tetracarboxylic dianhydride and a diamine, which has a glass transition temperature of 240° C. or higher or has no clear transition point at 300° C. or higher.

[0079] The polyimide porous film that can be used in the present invention is preferably a polyimide porous film made of the following aromatic polyimides, from the viewpoints of heat resistance and dimensional stability at high temperatures. (i) an aromatic polyimide comprising at least one tetracarboxylic acid unit selected from the group consisting of biphenyltetracarboxylic acid units and pyromellitic acid units, and an aromatic diamine unit; (ii) an aromatic polyimide comprising a tetracarboxylic acid unit and at least one aromatic diamine unit selected from the group consisting of a benzenediamine unit, a diaminodiphenyl ether unit and a bis(aminophenoxy)phenyl unit; and / or (iii) An aromatic polyimide comprising at least one tetracarboxylic acid unit selected from the group consisting of biphenyltetracarboxylic acid units and pyromellitic acid units, and at least one aromatic diamine unit selected from the group consisting of benzenediamine units, diaminodiphenyl ether units, and bis(aminophenoxy)phenyl units.

[0080] The polyimide porous film used in the present invention is preferably a three-layered polyimide porous film having surface layers A and B each having a plurality of pores, and a macrovoid layer sandwiched between the surface layers A and B, wherein the average pore size of the pores in the surface layer A is 0.01 μm to 15 μm, and the average pore size of the pores in the surface layer B is 20 μm to 100 μm, the macrovoid layer has partition walls bonded to the surface layers A and B, and a plurality of macrovoids surrounded by the partition walls and the surface layers A and B, the partition walls of the macrovoid layer and the surface layers A and B have thicknesses of 0.01 to 20 μm, the pores in the surface layers A and B are connected to the macrovoids, the polyimide porous film has a total thickness of 5 to 500 μm, and a porosity of 40% or more and less than 95%. At least one partition wall in the macrovoid layer has one or more pores that communicate with adjacent macrovoids and have an average pore size of 0.01 to 100 μm, preferably 0.01 to 50 μm.

[0081] For example, the polyimide porous films described in WO 2010 / 038873, JP 2011-219585 A, and JP 2011-219586 A can also be used in the present invention.

[0082] 6. Application of chondrocytes to modularized polyimide porous membranes The specific steps for applying cells to the modularized polyimide porous membrane are not particularly limited. The steps described herein or any method suitable for applying chondrocytes to a membrane-like carrier can be adopted. Although not limited thereto, in the method of the present invention, the application (seeding) of chondrocytes to the modularized polyimide porous membrane may include, for example, the following aspects. (1) applying a first culture medium containing suspended chondrocytes to a modularized polyimide porous membrane; (2) maintaining the modularized polyimide porous membrane at a temperature suitable for cell culture, and allowing the cells to be adsorbed to the polyimide porous membrane in the modularized polyimide porous membrane; and (3) a step of floating the modularized polyimide porous membrane having the cells adsorbed thereon in a medium without being fixed in a cell culture vessel for suspension culture, and culturing the modularized polyimide porous membrane in a second medium while shaking and / or stirring the membrane in a rotating motion, a reciprocating motion, an up-down motion, a wave-type rocking motion, a rotating motion, or a combination of these motions; Includes.

[0083] A model diagram of cell culture using a modularized polyimide porous membrane is shown in FIG. 4. FIG. 4 is a diagram for aiding understanding, and each element is not drawn to scale. In the cell culture method of the present invention, cells are applied to a modularized polyimide porous membrane and cultured, and a large number of cells grow in the multifaceted interconnected porous parts and surfaces of the polyimide porous membrane, making it possible to culture a large number of cells easily. In addition, in the cell culture method of the present invention, it is possible to culture a large number of cells while significantly reducing the amount of medium used for cell culture compared to conventional methods. For example, a large number of cells can be cultured for a long period of time even if a part or the entire polyimide porous membrane is not in contact with the liquid phase of the cell culture medium. In addition, it is also possible to significantly reduce the total volume of the cell culture medium contained in the cell culture vessel relative to the total volume of the polyimide porous membrane including the cell survival area.

[0084] In this specification, the volume occupied by the polyimide porous membrane without cells, including the volume of its internal gap, is referred to as the "apparent polyimide porous membrane volume" (see FIG. 4). Then, when cells are applied to the polyimide porous membrane and the cells are supported on the surface and inside of the polyimide porous membrane, the volume occupied by the polyimide porous membrane, the cells, and the culture medium infiltrated inside the polyimide porous membrane as a whole in the space is referred to as the "polyimide porous membrane volume including the cell survival area" (see FIG. 4). In the case of a polyimide porous membrane with a thickness of 25 μm, the polyimide porous membrane volume including the cell survival area is a value up to about 50% larger than the apparent polyimide porous membrane volume. In the method of the present invention, a plurality of polyimide porous membranes can be accommodated and cultured in one cell culture vessel. In this case, the sum of the polyimide porous membrane volumes including the cell survival area for each of the plurality of polyimide porous membranes supporting cells may be simply described as the "sum of the polyimide porous membrane volumes including the cell survival area".

[0085] By using the modularized polyimide porous membrane, it becomes possible to culture cells well for a long period of time even under conditions where the total volume of the cell culture medium contained in the cell culture vessel is 10,000 times or less than the total volume of the polyimide porous membrane including the cell survival area. Also, cells can be cultured well for a long period of time even under conditions where the total volume of the cell culture medium contained in the cell culture vessel is 1,000 times or less than the total volume of the polyimide porous membrane including the cell survival area. Furthermore, cells can be cultured well for a long period of time even under conditions where the total volume of the cell culture medium contained in the cell culture vessel is 100 times or less than the total volume of the polyimide porous membrane including the cell survival area. And, cells can be cultured well for a long period of time even under conditions where the total volume of the cell culture medium contained in the cell culture vessel is 10 times or less than the total volume of the polyimide porous membrane including the cell survival area.

[0086] That is, according to the present invention, the space (container) for cell culture can be made as small as possible compared to conventional cell culture devices for two-dimensional culture. In addition, when the number of cells to be cultured is to be increased, the volume for cell culture can be flexibly increased by a simple operation such as increasing the number of polyimide porous membranes to be laminated. With a cell culture device equipped with the polyimide porous membrane used in the present invention, it is possible to separate the space (container) for cell culture and the space (container) for storing the cell culture medium, and it is possible to prepare the required amount of cell culture medium according to the number of cells to be cultured. The space (container) for storing the cell culture medium may be enlarged or small depending on the purpose, or may be a replaceable container, and is not particularly limited.

[0087] In the method of the present invention, for example, the number of cells contained in the cell culture vessel after the culture using the polyimide porous membrane is 1.0 × 10 per milliliter of medium, assuming that all the cells are uniformly dispersed in the cell culture medium contained in the cell culture vessel. 5 pcs or more, 1.0×10 6 pcs or more, 2.0×10 6 pcs or more, 5.0×10 6 pcs or more, 1.0×10 7 pcs or more, 2.0×10 7 pcs or more, 5.0×10 7 pcs or more, 1.0×10 8 pcs or more, 2.0×10 8 pcs or more, 5.0×10 8 pcs or more, 1.0×10 9 pcs or more, 2.0×10 9 pcs or more, or 5.0×10 9 The cells can be cultured until they have more than one cell.

[0088] In this specification, the term "medium" refers to a cell culture medium for culturing cells, particularly animal cells. The term "medium" is used synonymously with the term "cell culture fluid." Therefore, the medium used in the present invention refers to a liquid medium. The type of medium may be any commonly used medium, and is appropriately determined depending on the type of cells to be cultured.

[0089] In culturing the cells of the present invention, the first medium used in step (1) is not particularly limited as long as it is a medium capable of culturing cells. For example, when culturing CHO cells, BalanCD (trademark) CHO GROWTH A manufactured by Irvine Scientific can be used.

[0090] In the cell culture of the present invention, the temperature at which cells can be cultured in step (2) may be any temperature at which cells can be adsorbed to the polyimide porous membrane, and is 10° C. to 45° C., preferably 15° C. to 42° C., more preferably 20° C. to 40° C., and even more preferably 25° C. to 39° C. In addition, in the cell culture method of the present invention, the time for adsorbing cells in step (2) is, for example, 5 minutes to 24 hours, preferably 10 minutes to 12 hours, and more preferably 15 minutes to 500 minutes.

[0091] In the culture of the cells of the present invention, in the step (2), the cells may be adsorbed to the polyimide porous membrane of the modularized polyimide porous membrane while shaking and / or stirring, or may be left to stand to allow the cells to be adsorbed to the polyimide porous membrane of the modularized polyimide porous membrane. The shaking method is not particularly limited, but for example, a culture vessel containing the modularized polyimide porous membrane of the present invention and the cells may be placed on a commercially available shaking device and shaken. The shaking may be performed continuously or intermittently, for example, shaking and standing may be repeated alternately, and may be appropriately adjusted. The stirring method is not particularly limited, but for example, the modularized polyimide porous membrane of the present invention and the cells may be placed in a commercially available spinner flask and stirred by rotating a stirrer. The stirring may be performed continuously or intermittently, for example, stirring and standing may be repeated alternately, and may be appropriately adjusted.

[0092] In the cell culture of the present invention, the second medium used in the step (3) is selected from the medium used for culturing adherent cells, and may be, but is not limited to, D-MEM, E-MEM, IMDM, Ham's F-12, etc. The second medium is preferably a medium that does not contain a component that inhibits the adhesion of cells to a substrate, such as a surfactant. The second medium used is appropriately selected depending on the type of cells. In the step (3), culturing in the second medium promotes the adhesion of the cells adsorbed to the polyimide porous membrane in the step (2) into the polymer porous membrane. This allows the cells to be stably cultured without falling off the polyimide porous membrane. In addition, the cell culture method of the present invention uses a modularized polyimide porous membrane equipped with the aforementioned polyimide porous membrane. The modularized polyimide porous membrane used in the cell culture method of the present invention is prevented from continuously deforming in shape within the casing by the polyimide porous membrane being housed in the casing. This prevents stress from being applied to the cells growing within the polyimide porous film, suppresses apoptosis and the like, and enables stable and large-scale cell culture.

[0093] In the cell culture of the present invention, the step (3) can be applied to commercially available culture vessels, culture devices, and systems for culturing cells. For example, the culture vessel may be a flexible bag-type culture vessel, and the culture can be performed in a culture vessel such as a stirring reactor, for example, a spinner flask. In addition, the culture vessel can be applied to an open vessel or a closed vessel. For example, a petri dish, flask, plastic bag, test tube, or large tank for cell culture can be appropriately used. For example, the cell culture dish manufactured by BD Falcon and the Nunc Cell Factory manufactured by Thermo Scientific are included. In addition, by using the modularized polyimide porous membrane in the cell culture method of the present invention, it becomes possible to culture cells that were not originally capable of suspension culture in a suspension culture-like state in a suspension culture-oriented device. For example, a stirring reactor such as a Corning spinner flask can be used as the suspension culture device. In addition, the step (3) can be performed in the cell culture device described in the present specification.

[0094] In the culture of the cells of the present invention, the step (3) can also be carried out using a continuous circulation type device that continuously adds and recovers culture medium to a culture vessel containing the modularized polyimide porous membrane.

[0095] In the cell culture of the present invention, the step (3) may be a system in which the cell culture medium is continuously or intermittently supplied into the cell culture vessel from a cell culture medium supplying means installed outside the culture vessel containing the modularized polyimide porous membrane, and the cell culture medium may be circulated between the cell culture medium supplying means and the cell culture vessel.

[0096] 7. Chondrocyte Culture Conditions In the method of the present invention, a commercially available culture vessel, culture device, and system can be used as long as the modularized polyimide porous membrane is suspended in a medium without being fixed in a cell culture vessel for suspension culture, and the modularized polyimide porous membrane can be stirred in a rotating motion, a reciprocating motion, an up-down motion, a wave-shaped rocking motion, a rotational motion, or a combination of these motions. For example, the culture vessel may be a flexible bag-type culture vessel, and culture can also be performed in a culture vessel such as a stirring reactor, for example, a spinner flask. In addition, the culture vessel can be applied to an open vessel or a closed vessel. For example, a petri dish, flask, plastic bag, test tube, or large tank for cell culture can be appropriately used. For example, a cell culture dish manufactured by BD Falcon and a Nunc Cell Factory manufactured by Thermo Scientific are included. In addition, by using a modularized polyimide porous membrane in the cell culture method of the present invention, it becomes possible to culture cells that were not originally capable of suspension culture in a suspension culture-like state in a device for suspension culture. As an apparatus for suspension culture, for example, a stirring reactor such as a spinner flask manufactured by Corning Incorporated can be used.

[0097] In one embodiment, the cell culture vessel that can be used in the present invention may be a culture vessel selected from the group consisting of a flask, a culture bottle, a culture dish, a culture bag, and a stirred reactor.

[0098] In this specification, the term "swirling motion" refers to a motion in which the culture vessel is rotated on a plane parallel to the horizontal plane to stir the liquid in the culture vessel. When the swirling motion is applied to the present invention, a commercially available culture shaker, for example, a swirling shaker, may be used. The swirling motion applied to the present invention may be performed, for example, at 40 rpm to 150 rpm. The swirling motion applied to the present invention may be performed, for example, with a swirling diameter of 0.5 to 10 cm.

[0099] In this specification, "reciprocating motion" refers to a motion in which the culture vessel is moved left and right or back and forth to stir the liquid in the culture vessel. When reciprocating motion is applied to the present invention, a commercially available culture shaker, for example, a reciprocating shaking shaker, may be used. The reciprocating motion applied to the present invention may be performed at, for example, 40 reciprocations / min to 150 reciprocations / min. The travel distance of the reciprocating motion applied to the present invention may be, for example, 0.5 to 10 cm.

[0100] In this specification, "up-and-down movement" refers to a movement in which the culture vessel is moved up and down in the vertical direction to stir the liquid in the culture vessel. When applying up-and-down movement, a commercially available culture shaker, for example, an up-and-down shaking shaker, may be used. The up-and-down movement applied in the present invention may be performed at, for example, 40 reciprocations / min to 150 reciprocations / min. The travel distance of the reciprocating movement applied in the present invention may be, for example, 0.5 to 10 cm.

[0101] In this specification, the term "wave-type rocking motion" refers to a motion that generates a wave motion in the liquid in the culture vessel by a seesaw motion back and forth and / or left and right, thereby stirring the liquid. In order to perform the wave-type rocking motion, a commercially available culture shaker, for example, a WAVE reactor, may be used. The wave-type rocking motion applied in the present invention may be, for example, rocking the bottom surface of the cell culture vessel with an inclination in the range of 4 degrees to 15 degrees. In addition, the wave-type rocking motion applied in the present invention may be, for example, performed at 5 rpm to 25 rpm.

[0102] In this specification, the term "rotational movement" refers to a movement in which the liquid in the culture vessel is stirred by rotating a physical stirring means. In order to perform the rotational movement, for example, a stirring reactor, such as a spinner flask or a stationary stirring reactor having a stirring blade, may be used. The rotational movement applied in the present invention may be performed at, for example, 10 rpm to 300 rpm.

[0103] In the present invention, the modularized polyimide porous membrane to which cells are applied is cultured while being shaken and / or stirred in a state of rotational motion, reciprocating motion, up-down motion, wave-type rocking motion, rotational motion, or a combination of these motions. In one embodiment, the present invention uses a culture bag as a culture vessel, and cultures the modularized polyimide porous membrane while being stirred in a state of rotational motion and wave-type rocking motion by using a culture shaker. This makes it possible to stably and efficiently produce a scaffold-free three-dimensional cartilage tissue.

[0104] In one embodiment of the present invention, long-term culture can be achieved by intermittently replacing the medium.

[0105] In the present invention, chondrocytes may be continuously cultured. For example, the culture in the method of the present invention can be performed in a continuous circulation or open type apparatus in which a medium is continuously added to and collected from a modularized porous polyimide membrane, exposing the porous polyimide membrane to air.

[0106] In the present invention, chondrocytes may be cultured in a system in which a cell culture medium is continuously or intermittently supplied into the cell culture vessel from a cell culture medium supplying means installed outside the cell culture vessel, in which the cell culture medium circulates between the cell culture medium supplying means and the cell culture vessel.

[0107] The present invention includes an embodiment including culturing chondrocytes by installing the cell culture device in an incubator. The present invention also includes an embodiment including culturing cells in a standalone cell culture device such as a bench-top reactor. When the cell culture is performed in a system in which a cell culture medium is continuously or intermittently supplied into the cell culture container from a cell culture medium supplying means installed outside the cell culture container, the system may be a cell culture device including a culture unit which is a cell culture container and a culture medium supplying unit which is a cell culture medium supplying means, wherein the culture unit is a culture unit that houses one or more modularized polyimide porous membranes for supporting cells and is provided with a culture medium inlet and a culture medium outlet, and the culture medium supplying unit is a cell culture device that includes a culture medium storage container, a culture medium supplying line, and a liquid delivery pump that delivers the culture medium through the culture medium supplying line, wherein a first end of the culture medium supplying line contacts the culture medium in the culture medium storage container, and a second end of the culture medium supplying line communicates with the inside of the culture unit through the culture medium supplying port of the culture unit.

[0108] In the above cell culture device, the culture unit may be a culture unit that does not include a culture medium supply line, a liquid feed pump, an air supply port, and an air exhaust port, or may be a culture unit that includes a culture medium supply line, a liquid feed pump, an air supply port, and an air exhaust port. The culture unit may not include an air supply port and an air exhaust port. Furthermore, in the above cell culture device, the culture unit may further include a culture medium discharge line, where a first end of the culture medium discharge line is connected to a culture medium storage container and a second end of the culture medium discharge line is connected to the inside of the culture unit via the culture medium exhaust port of the culture unit, and the culture medium may be circulated between the culture medium supply unit and the culture unit.

[0109] II. Kit The present invention further relates to a kit for use in the method of the present invention, which includes a modularized polyimide porous membrane. The kit of the present invention may appropriately include components necessary for culturing chondrocytes in addition to the modularized polyimide porous membrane. For example, the kit may include cells to be applied to the modularized polyimide porous membrane, a cell culture medium, a continuous medium supplying device, a continuous medium circulating device, a cell culture device, an evaluation means for confirming cartilage tissue, and an instruction manual for the kit.

[0110] III.Use The present invention further includes the use of the modularized polyimide porous membrane for the above-mentioned method of the present invention.

[0111] The present invention will be described in detail below with reference to examples, but the present invention is not limited to these examples. Those skilled in the art can easily modify and alter the present invention based on the description in this specification, and such modifications and alterations are within the technical scope of the present invention. EXAMPLES

[0112] The polymer porous membrane used in the following examples is a polyimide porous membrane, which was prepared by molding a polyamic acid solution composition containing a polyamic acid solution obtained from 3,3',4,4'-biphenyltetracarboxylic dianhydride (s-BPDA) as a tetracarboxylic acid component and 4,4'-diaminodiphenyl ether (ODA) as a diamine component, and polyacrylamide as a coloring precursor, and then heat-treating the polyimide porous membrane at 250°C or higher. The obtained polyimide porous membrane was a three-layered polyimide porous membrane having a surface layer A and a surface layer B having a plurality of pores, and a macrovoid layer sandwiched between the surface layer A and the surface layer B, and the average pore size of the pores present in the surface layer A was 19 μm, the average pore size of the pores present in the surface layer B was 42 μm, the membrane thickness was 25 μm, and the porosity was 74%.

[0113] 1. Experimental Method 1-1.Culture method <Example> Human chondrocytes (Y39_) at the second passage, cultured on IWAKI collagen I-coated dishes (Articular Engineering), were detached using Gibco Trypsin-EDTA (0.05%) and phenol red, and suspended in medium (PromoCell Chondrocyte Growth Medium, adjusted to 3000 mg / L with glucose added) (7.51 × 10 5 cells / mL).

[0114] Four 150 mL storage bottles manufactured by Corning were prepared, and one moistened and sterilized modularized polyimide porous membrane (FIG. 5, hereafter referred to as "Device 1" in this Example) and 20 mL of medium (xeno-free medium manufactured by Kohjin Bio Co., Ltd.; medium adjusted to 3000 mg / L by adding glucose to KBM ADSC-4) were placed in each bottle, and the bottles were then placed in a CO2 incubator (aniCell) equipped with a humidified shaker manufactured by N-BIOTEK, set at 37°C, and shaken at 80 rpm for 1 hour to complete preparation for seeding. The above cell suspension (7.51 x 10 5 719 μL of 5.4 × 10 cells / mL was added and cultured with shaking for 1 day (seeding number: 5.4 × 10 5 The next day, 10 mL of glucose-adjusted KBM ADSC-4 medium was added to each bottle. Two bottles were then cultured with shaking at 80 rpm, and the remaining two bottles were transferred to an Astec CO2 incubator (APM-30D) for static culture. The medium was replaced twice a week with glucose-adjusted KBM ADSC-4 medium.

[0115] <Comparative Example: Atelocollagen Embedding> The above cell suspension (7.51 × 10 5 The cells were pelleted by centrifugation at 220 × g for 3 min and then suspended in medium to prepare a cell suspension (4.0 × 10 6The cell suspension and 3% atelocollagen solution (Koken) were mixed at a ratio of 1:1 on ice. Two FALCON dishes were prepared, and the atelocollagen solution containing chondrocytes (2.0 × 10 6 270μL of cells / mL was dropped onto each イ 5.4×10 5 The dishes were placed in an Astec CO2 incubator (APM-30D) and left to gel for 1-2 hours. イ 12 mL of glucose-adjusted KBM ADSC-4 medium was added to the culture medium. Culture medium was replaced twice a week with glucose-adjusted KBM ADSC-4 medium.

[0116] 1-2.DNA quantification The cartilage autologous tissue (Example) or atelocollagen gel (Comparative Example) on the 50th to 52nd day of culture was collected, washed with 4 mL of PBS, transferred to a 15 mL tube, and homogenized with 800 μL of lysis buffer. 80 μL of proteinase K was added to each tube, mixed, and placed in a thermostatic shaker and left to stand overnight at 55 ° C. The next day, 293 μL of 5M NaCl was added, centrifuged at 15000 × g for 10 minutes, and the supernatant was collected in a new tube. 587 μL of isopropanol was added to the supernatant, and the precipitate was collected by centrifugation at 15000 × g for 3 minutes. 880 μL of sterile water was added to the precipitate, and the precipitate was dissolved by incubating in a water bath at 37 ° C. for 2 hours. After that, 8 μL of RNase (10 mg / mL) was added and incubated at 37°C for 1 hr, after which 293 μL of 5M NaCl was added and centrifuged at 15,000×g for 10 min, and the supernatant was collected in a new tube. 587 μL of isopropanol was added to the collected supernatant, and the precipitate was collected by centrifugation at 15,000×g for 3 min, and washed twice with 1 mL of 70% ethanol. After air drying, the precipitate was dissolved by adding 100 μL of sterile water at 37°C. The DNA concentration in the obtained aqueous solution was measured using a nanodrop.

[0117] 1-3. Quantitation of glycosaminoglycans The samples were washed with PBS, homogenized, and 2 mL of papain extraction reagent was added. The mixture was incubated at 65°C for 27 hours and then centrifuged at 10,000 x g for 10 minutes. The GAG ​​in the resulting supernatant was quantified using the Blyscan Glycosaminoglycan Assay Kit.

[0118] 2. Experimental Results As a result of the above, a cartilage tissue having the following properties was obtained (FIGS. 6 and 7). [Table 1]

Claims

1. A method for producing a scaffold-free three-dimensional cartilage tissue construct, comprising: a step of culturing the modularized polyimide porous membrane seeded with chondrocytes while applying shear stress to the modularized polyimide porous membrane, while floating the modularized polyimide porous membrane in a medium in a cell culture vessel for suspension culture in an unfixed state; Including, The modularized polyimide porous membrane comprises a polyimide porous membrane and a casing in which the polyimide porous membrane is housed, and the polyimide porous membrane is fixed to the casing in a state in which the polyimide porous membrane does not continuously undergo wavy motion due to a fluid, The casing has one or more medium inlet / outlet ports for exposing a medium to at least a portion of the surface of the polyimide porous membrane; wherein the polyimide porous film is a three-layered polyimide porous film having surface layers A and B each having a plurality of pores, and a macrovoid layer sandwiched between the surface layers A and B, wherein the average pore size of the pores in the surface layer A is smaller than the average pore size of the pores in the surface layer B, the macrovoid layer has partition walls bonded to the surface layers A and B, and a plurality of macrovoids surrounded by the partition walls and the surface layers A and B, and the pores in the surface layers A and B are connected to the macrovoids. The method.

2. The method according to claim 1 , wherein the modularized polyimide porous film is contained in a stack of two or more of the polyimide porous films.

3. The method according to claim 1, wherein the shear stress is induced by shaking and / or stirring while undergoing a swirling motion, a reciprocating motion, an up-and-down motion, a wave-type rocking motion, a rotational motion, or a combination of these motions.

4. The method of claim 1, wherein the polyimide porous membrane has a plurality of pores having an average pore size of 0.01 to 100 μm.

5. The method according to claim 1, wherein the average pore size of the surface layer A is 0.01 to 50 μm.

6. The method according to claim 1, wherein the average pore size of the surface layer B is 20 to 100 μm.

7. 2. The method according to claim 1, wherein the total thickness of the polyimide porous film is 5 to 500 μm.

8. The method according to claim 1 , wherein the polyimide porous film is a polyimide porous film comprising a polyimide obtained from a tetracarboxylic dianhydride and a diamine.

9. 2. The method according to claim 1, wherein the polyimide porous film is a colored polyimide porous film obtained by molding a polyamic acid solution composition containing a polyamic acid solution obtained from a tetracarboxylic dianhydride and a diamine and a colored precursor, and then heat-treating the resulting product at 250° C. or higher.

10. A scaffold-free three-dimensional cartilage tissue obtained by the method according to claim 1.

11. A scaffold-free three-dimensional cartilage tissue comprising chondrocytes, The present invention does not include any externally added scaffold components other than the extracellular matrix produced by the chondrocytes, The scaffold-free three-dimensional cartilage tissue has an average thickness of 0.2 mm or more, A scaffold-free three-dimensional cartilage tissue, characterized in that it contains 5 μg or more of glycosaminoglycan per 1 mg of wet weight.

12. The scaffold-free three-dimensional cartilage tissue according to claim 11, wherein the scaffold-free three-dimensional cartilage tissue has an average thickness of 0.5 mm or more.

Citation Information

Patent Citations

  • Material for implanting cartilage and method of manufacturing the same

    JP2001293081A

  • Spheroid for cell transplantation treatment composed of cell mixture and method for preparing the same

    JP2011041472A

  • Porous polyimide film and method for producing the same

    JP2011219585A

  • Porous polyimide film and method for producing the same

    JP2011219586A

  • Cultured cell sheet, production method thereof, and application method thereof

    JP2014155494A